RU96107203A - Моноклональные антитела, обладающие способностью вызывать апоптоз - Google Patents
Моноклональные антитела, обладающие способностью вызывать апоптозInfo
- Publication number
- RU96107203A RU96107203A RU96107203/13A RU96107203A RU96107203A RU 96107203 A RU96107203 A RU 96107203A RU 96107203/13 A RU96107203/13 A RU 96107203/13A RU 96107203 A RU96107203 A RU 96107203A RU 96107203 A RU96107203 A RU 96107203A
- Authority
- RU
- Russia
- Prior art keywords
- ability
- monoclonal antibodies
- cause apoptosis
- myeloid cells
- monoclonal antibody
- Prior art date
Links
- 102000005614 monoclonal antibodies Human genes 0.000 title claims 4
- 108010045030 monoclonal antibodies Proteins 0.000 title claims 4
- 206010059512 Apoptosis Diseases 0.000 title 1
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 title 1
- 230000006907 apoptotic process Effects 0.000 title 1
- 229960000060 monoclonal antibodies Drugs 0.000 title 1
- 210000000066 Myeloid Cells Anatomy 0.000 claims 2
- 230000031957 myeloid cell apoptotic process Effects 0.000 claims 2
- 210000004408 Hybridomas Anatomy 0.000 claims 1
Claims (3)
1. Моноклональное антитело, обладающее способностью вызывать апоптоз миелоидных клеток посредством связывания с миелоидными клетками.
2. Фрагменты моноклонального антитела, обладающие способностью вызывать апоптоз миелоидных клеток посредством связывания с миелоидными клетками.
3. Гибридома, продуцирующая моноклональное антитело по п.1.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP05242110 | 1993-09-03 | ||
| JP5/242110 | 1993-09-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU96107203A true RU96107203A (ru) | 1998-07-20 |
| RU2202615C2 RU2202615C2 (ru) | 2003-04-20 |
Family
ID=17084452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU96107203/13A RU2202615C2 (ru) | 1993-09-03 | 1994-09-02 | Моноклональное антитело, способное распознавать антиген, вызывающий апоптоз миелоидных клеток костного мозга, и обладающее свойством вызывать апоптоз миеломных клеток, его фрагмент и гибридома |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US5840344A (ru) |
| EP (1) | EP0721015B1 (ru) |
| KR (1) | KR100241863B1 (ru) |
| CN (1) | CN1046314C (ru) |
| AT (1) | ATE280835T1 (ru) |
| AU (1) | AU692466B2 (ru) |
| CA (1) | CA2169950A1 (ru) |
| CZ (1) | CZ294359B6 (ru) |
| DE (1) | DE69434097T2 (ru) |
| FI (1) | FI960567A0 (ru) |
| HU (1) | HU222989B1 (ru) |
| NO (1) | NO960684D0 (ru) |
| PL (1) | PL181783B1 (ru) |
| RU (1) | RU2202615C2 (ru) |
| SK (1) | SK281964B6 (ru) |
| TW (1) | TW426687B (ru) |
| UA (1) | UA50708C2 (ru) |
| WO (1) | WO1995006748A1 (ru) |
| ZA (1) | ZA946767B (ru) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006748A1 (fr) * | 1993-09-03 | 1995-03-09 | Chugai Seiyaku Kabushiki Kaisha | Anticorps monoclonal permettant d'induire une apoptose |
| WO1997032601A1 (fr) * | 1996-03-06 | 1997-09-12 | Chugai Seiyaku Kabushiki Kaisha | Procede de criblage de substances induisant l'apoptose |
| ES2242227T5 (es) | 1996-07-15 | 2011-12-09 | Chugai Seiyaku Kabushiki Kaisha | Nuevo factor de tipo vegf. |
| US7531643B2 (en) | 1997-09-11 | 2009-05-12 | Chugai Seiyaku Kabushiki Kaisha | Monoclonal antibody inducing apoptosis |
| HUP0003513A3 (en) * | 1997-09-11 | 2004-05-28 | Chugai Pharmaceutical Co Ltd | Monoclonal antibody inducing apoptosis |
| WO2000053634A1 (fr) * | 1999-03-10 | 2000-09-14 | Chugai Seiyaku Kabushiki Kaisha | Fv monocatenaire induisant l'apoptose |
| US7696325B2 (en) | 1999-03-10 | 2010-04-13 | Chugai Seiyaku Kabushiki Kaisha | Polypeptide inducing apoptosis |
| US20040058393A1 (en) * | 2000-04-17 | 2004-03-25 | Naoshi Fukishima | Agonist antibodies |
| CN1308447C (zh) * | 2000-10-20 | 2007-04-04 | 中外制药株式会社 | 低分子化的激动剂抗体 |
| ATE391174T1 (de) | 2000-10-20 | 2008-04-15 | Chugai Pharmaceutical Co Ltd | Modifizierter tpo-agonisten antikörper |
| US7195771B1 (en) | 2000-11-21 | 2007-03-27 | Kimberly-Clark Worldwide, Inc. | Water-soluble lotions for paper products |
| WO2003044482A2 (en) * | 2001-11-16 | 2003-05-30 | The University Of Tennessee Research Corporation | Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
| DE60324700D1 (de) * | 2002-10-11 | 2008-12-24 | Chugai Pharmaceutical Co Ltd | Zelltod-induzierender wirkstoff |
| JP2004279086A (ja) * | 2003-03-13 | 2004-10-07 | Konica Minolta Holdings Inc | 放射線画像変換パネル及び放射線画像変換パネルの製造方法 |
| US20070003556A1 (en) * | 2003-03-31 | 2007-01-04 | Masayuki Tsuchiya | Modified antibodies against cd22 and utilization thereof |
| TW200530269A (en) | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Anti-Mpl antibodies |
| CA2548929A1 (en) * | 2003-12-12 | 2005-06-23 | Chugai Seiyaku Kabushiki Kaisha | Cell death inducing agent |
| JPWO2005056602A1 (ja) * | 2003-12-12 | 2008-03-06 | 中外製薬株式会社 | アゴニスト活性を有する改変抗体のスクリーニング方法 |
| TW200530266A (en) * | 2003-12-12 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Method of reinforcing antibody activity |
| EP1870458B1 (en) * | 2005-03-31 | 2018-05-09 | Chugai Seiyaku Kabushiki Kaisha | sc(Fv)2 STRUCTURAL ISOMERS |
| WO2006123724A1 (ja) * | 2005-05-18 | 2006-11-23 | The University Of Tokushima | 抗hla抗体を利用した新規医薬品 |
| CN101262885B (zh) * | 2005-06-10 | 2015-04-01 | 中外制药株式会社 | 含有sc(Fv)2的药物组合物 |
| CA2610987C (en) | 2005-06-10 | 2013-09-10 | Chugai Seiyaku Kabushiki Kaisha | Stabilizer for protein preparation comprising meglumine and use thereof |
| US20080038237A1 (en) * | 2006-02-28 | 2008-02-14 | Sapolsky Robert M | Trojan horse immunotherapy |
| JPWO2008007755A1 (ja) * | 2006-07-13 | 2009-12-10 | 中外製薬株式会社 | 細胞死誘導剤 |
| CL2008000719A1 (es) * | 2007-03-12 | 2008-09-05 | Univ Tokushima Chugai Seiyaku | Agente terapeutico para cancer resistente a agentes quimioterapeuticos que comprende un anticuerpo que reconoce hla de clase i como ingrediente activo; composicion farmaceutica que comprende dicho anticuerpo; y metodo para tratar cancer resistente a |
| SG10202008076RA (en) | 2014-12-05 | 2020-09-29 | Memorial Sloan Kettering Cancer Center | Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof |
| CA3007115A1 (en) | 2015-12-04 | 2017-06-08 | Memorial Sloan-Kettering Cancer Center | Antibodies targeting fc receptor-like 5 and methods of use |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995006748A1 (fr) * | 1993-09-03 | 1995-03-09 | Chugai Seiyaku Kabushiki Kaisha | Anticorps monoclonal permettant d'induire une apoptose |
| WO1997032601A1 (fr) * | 1996-03-06 | 1997-09-12 | Chugai Seiyaku Kabushiki Kaisha | Procede de criblage de substances induisant l'apoptose |
| HUP0003513A3 (en) * | 1997-09-11 | 2004-05-28 | Chugai Pharmaceutical Co Ltd | Monoclonal antibody inducing apoptosis |
| WO2000053634A1 (fr) * | 1999-03-10 | 2000-09-14 | Chugai Seiyaku Kabushiki Kaisha | Fv monocatenaire induisant l'apoptose |
-
1994
- 1994-09-02 WO PCT/JP1994/001453 patent/WO1995006748A1/ja active IP Right Grant
- 1994-09-02 CZ CZ1996617A patent/CZ294359B6/cs not_active IP Right Cessation
- 1994-09-02 RU RU96107203/13A patent/RU2202615C2/ru not_active IP Right Cessation
- 1994-09-02 HU HU9600206A patent/HU222989B1/hu not_active IP Right Cessation
- 1994-09-02 UA UA96030813A patent/UA50708C2/ru unknown
- 1994-09-02 SK SK255-96A patent/SK281964B6/sk unknown
- 1994-09-02 KR KR1019960700821A patent/KR100241863B1/ko not_active IP Right Cessation
- 1994-09-02 US US08/605,059 patent/US5840344A/en not_active Expired - Lifetime
- 1994-09-02 AT AT94925618T patent/ATE280835T1/de not_active IP Right Cessation
- 1994-09-02 EP EP94925618A patent/EP0721015B1/en not_active Expired - Lifetime
- 1994-09-02 PL PL94313260A patent/PL181783B1/pl not_active IP Right Cessation
- 1994-09-02 CN CN94193260A patent/CN1046314C/zh not_active Expired - Fee Related
- 1994-09-02 AU AU75466/94A patent/AU692466B2/en not_active Ceased
- 1994-09-02 CA CA002169950A patent/CA2169950A1/en not_active Abandoned
- 1994-09-02 ZA ZA946767A patent/ZA946767B/xx unknown
- 1994-09-02 DE DE69434097T patent/DE69434097T2/de not_active Expired - Fee Related
- 1994-11-19 TW TW083110887A patent/TW426687B/zh not_active IP Right Cessation
-
1996
- 1996-02-07 FI FI960567A patent/FI960567A0/fi not_active Application Discontinuation
- 1996-02-21 NO NO960684A patent/NO960684D0/no not_active Application Discontinuation
-
1998
- 1998-09-17 US US09/154,498 patent/US6267959B1/en not_active Expired - Lifetime
-
2000
- 2000-12-15 US US09/736,146 patent/US6759043B2/en not_active Expired - Fee Related
-
2003
- 2003-03-03 US US10/376,628 patent/US20030147894A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU96107203A (ru) | Моноклональные антитела, обладающие способностью вызывать апоптоз | |
| DE68914244D1 (de) | Monoklonaler Antikörper. | |
| CA2021594A1 (en) | Antibody to human interleukin-6 receptor | |
| EP0408859A3 (en) | Monoclonal antibodies to activated endothelial cells | |
| EP0059754A4 (en) | IMMUNOLOGICAL ANALYSIS USING HIGH AFFINITY MONOCLONIC IgM ANTIBODIES. | |
| DE3382283D1 (de) | Monoklonale antikoerper spezifisch gegen das karzinoembryonische antigen. | |
| DE3484773D1 (de) | Mit endotoxinkern reaktionsfaehige monoklonale antikoerper. | |
| NO910922L (no) | Tris-maleimidoforbindelser som mellomprodukter i trifunksjonell antistoffsyntese. | |
| EP0568631A4 (en) | MONOCLONAL ANTIBODIES FOR A CELL SURFACE RECEPTOR (ELAM-1) AND USES THEREOF. | |
| EP0212403A3 (en) | Monoclonal antibodies to mucin-like human differentiation antigens | |
| IT1271461B (it) | Anticorpo monoclonale bispecifico anti-cd3/anti-egfr,processo per la produzione e suo uso. | |
| DK162170C (da) | Monoklonale antistoffer, der er reaktive mod eimeriaarters merozoitter | |
| DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
| GB2153364B (en) | Lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
| CA2080548A1 (en) | Monoclonal antibodies to hepatitis c virus | |
| AU629954B2 (en) | Monoclonal antibodies directed against activated microglial cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications | |
| DK557289A (da) | Monoklonalt, fucosylceramiderkendende antistof, dets fremstilling og anvendelse samt hybridoma til fremstillingen | |
| GB2168355B (en) | Novel lymphokine, monoclonal antibody specific to the lymphokine, and their production and uses | |
| DK49291D0 (da) | Gramnegativ-bakterieendotoxinblokerende, monoklonale antistoffer | |
| RU97119175A (ru) | Гибридома, обозначенная 199м, и моноклональное антитело, секретированное этой гибридомой | |
| EP0538267A4 (en) | Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same | |
| NO894555L (no) | Monoklonalt antistoff som spesifikt gjenkjenner n-glycolyl type gm2, hybridom som produserer antistoff og fremgangsmaate for fremstilling av hybridomet. | |
| CA2065797A1 (en) | Monoclonal antibody, polypeptide and production thereof | |
| IL89308A (en) | Monoclonal antibodies exhibiting specificity to sialic acid glycolipid, hybridomas for producing said monoclonal antibodies and a process for preparing the hybridomas | |
| GB8816366D0 (en) | Hybridoma cells & monoclonal antibodies |